Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs11658079 | chr17:692520 | C/T | 5.63E-5 | 134 | 20.6 | 25.47 | 45.83 | KM Plot |
| TGCT | rs11662050 | chr18:32784946 | C/T | 9.74E-5 | 132 | 17.1 | 27.1 | 50.97 | KM Plot |
| TGCT | rs116661759 | chr6:15251537 | G/A | 3.36E-5 | 133 | 37.7 | 45.93 | NA | KM Plot |
| TGCT | rs117017165 | chr16:67646311 | G/A | 0 | 133 | 46.07 | 24.1 | 0.57 | KM Plot |
| TGCT | rs11718276 | chr3:125628689 | A/G | 2.9E-6 | 130 | 48.87 | 36.37 | 47.27 | KM Plot |
| TGCT | rs11730410 | chr4:541595 | C/T | 9.94E-7 | 134 | 41.27 | 47.68 | 53.82 | KM Plot |
| TGCT | rs11739552 | chr5:116553253 | A/G | 1.9E-13 | 131 | 46.3 | 28.8 | 17.1 | KM Plot |
| TGCT | rs11740602 | chr5:1822606 | G/A | 5.89E-6 | 133 | 42.27 | 43.9 | 24.73 | KM Plot |
| TGCT | rs11740753 | chr5:1812413 | G/A | 5.72E-6 | 133 | 42.27 | 43.9 | 24.73 | KM Plot |
| TGCT | rs11741881 | chr5:1832240 | T/C | 7.75E-9 | 129 | 42.18 | 51.67 | 24.73 | KM Plot |
| TGCT | rs117424242 | chr14:78131127 | G/A | 8.81E-5 | 132 | 45.47 | 38.2 | 18.07 | KM Plot |
| TGCT | rs117447021 | chr16:67669455 | G/A | 0 | 133 | 46.07 | 24.1 | 0.57 | KM Plot |
| TGCT | rs11746186 | chr5:116553503 | G/A | 1.9E-13 | 131 | 46.3 | 28.8 | 17.1 | KM Plot |
| TGCT | rs117473643 | chr7:128698186 | G/C | 1.87E-5 | 133 | 42.18 | 30.3 | 17.1 | KM Plot |
| TGCT | rs11748427 | chr5:1824205 | C/T | 5.89E-6 | 133 | 42.27 | 43.9 | 24.73 | KM Plot |